3654 results for «214»
3654 results
Featured research - TAVI: MELA, ViMech & more
17 Nov 2025 – From PCR London Valves 2025
This session presents cutting-edge research on Transcatheter Aortic Valve Implantation (TAVI), focusing on comparative outcomes between Myval and Evolut valves in large aortic annuli, the role of balloon post-dilation in self- and balloon-expandable valves, and novel valve-in-mechanical valve replacement approaches. Long-term follow-up data contrasting surgical aortic...
Featured research - TAVI: procedural optimization
17 Nov 2025 – From PCR London Valves 2025
Delve into comprehensive analyses of TAVI procedural outcomes and innovations in this session. Topics include the impact of intercoronary angles on coronary overlap with Evolut valves, mechanisms behind superior outcomes with the latest balloon-expandable valves, and predictive modeling of hemodynamics using physics-enhanced digital twins. Additionally, sex-specific...
TAVI: high coronary risk - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session addresses the challenges and solutions related to high coronary risk in TAVI procedures. Topics include advanced coronary protection strategies, innovative approaches to complex valve-in-valve interventions, the benefits of balloon-assisted techniques, management of right coronary cusp obstruction through UNICORN technology, and prevention of sinus sequestration...
TAVI: complex vascular access - Part 2
17 Nov 2025 – From PCR London Valves 2025
Focus on complex vascular access challenges in TAVI with this session covering strategies such as the pave and crack technique for inaccessible vessels, management of bicuspid aortic stenosis with hostile access and horizontal aorta, complex single transfemoral access procedures, and combined interventions including left atrial appendage...
Paravalvular leaks and VSD percutaneous closure - Recorded cases
17 Nov 2025 – From PCR London Valves 2025
Recorded case 1: A 56-year-old female with a prior mechanical mitral valve replacement (Star GK, 2018), permanent AF, and normal LV function presented with recurrent HF admissions due to paravalvular leaks. She was treated with implantation of multiple plugs via a transseptal approach using a Destination...
Tricuspid valve interventions in complex scenarios - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session delves into transcatheter interventions for the tricuspid valve in complex clinical scenarios. It covers techniques for native annular reduction via TEER, management of lead-related regurgitation, challenging cases of torrential regurgitation with device detachment, and innovative methods facilitating valve-in-ring implantation, enhancing procedural efficacy in tricuspid...
Cardiogenic shock: transcatheter solutions
17 Nov 2025 – From PCR London Valves 2025
This session focuses on transcatheter solutions for cardiogenic shock, highlighting rescue therapies such as mitral clip intervention in hypertrophic obstructive cardiomyopathy, valve-in-valve TAVI during CPR, and sequential mechanical circulatory support. It presents complex clinical cases illustrating stepwise approaches combining mechanical support and percutaneous valve repair to...
Leaflet modification techniques: latest acronyms, concepts and best practice
17 Nov 2025 – From PCR London Valves 2025
Gain comprehensive insights into leaflet modification techniques with a focus on the latest acronyms, concepts, and best practices. This session covers step-by-step approaches to transcatheter electrosurgical leaflet modification, including BASILICA, SHORTCUT, and UNICORN, alongside troubleshooting strategies and the innovative SURPLUS surgical technique.
Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry
17 Sep 2022
Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.
Author
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events
01 Sep 2022
Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.
Author
Cardiawave announces positive six-month data from valvosoft pivotal study at transcatheter cardiovascular therapeutics (TCT) conference
28 Oct 2024
EuroPCR 2024 – One-month DAPT followed by 5-month Ticagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.
Author
Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery (PROCTOR)
03 Nov 2025
Kalaivani Mahadevan and Trisha Singh provide their take on the PROCTOR study presented by Ruben de Winter at TCT 2025, in San Francisco.
Author
Author
